-
Mashup Score: 100Building Responsive and Adaptive Health Care Systems in Canada: Lessons from Switzerland - 1 month(s) ago
Canada’s health-care system is increasingly unable to meet patient needs, with wait times reaching record lengths—over 30 weeks for planned care in 2024—despite significantly rising public spending and growing dissatisfaction among patients and providers nationwide. Swiss health care outperforms Canada in nearly all OECD performance indicators: more doctors and nurses per capita, better access to care, shorter wait times, lower unmet needs, and higher patient satisfaction (94% vs. Canada’s 56%). Switzerlan
Source: www.fraserinstitute.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0A Reckoning Over Joe Biden’s Health - 2 month(s) ago
Podcast Episode · The Daily · 2025-05-20 · 36m
Source: podcasts.apple.comCategories: General Medicine NewsTweet-
thoughts and prayers to Joe Biden @nytimes shows they don’t understand cancer, or screening, or probability. “Because given the resources that he has to doctors and health care that it wasn't caught earlier was a little bit surprising to me.” https://t.co/Zj5h8KmyCs
-
-
Mashup Score: 0Screening for prostate cancer - 2 month(s) ago
Prostate cancer is one of the most prevalent forms of cancer in men worldwide. Screening for prostate cancer implies that diagnostic tests be performed in the absence of any symptoms or indications of disease. These tests include the digital rectal examination (DRE), the prostate-specific antigen (PSA) blood test and transrectal ultrasound (TRUS) guided biopsy. Screening aims to identify cancers at an early and treatable stage, therefore increasing the chances of successful treatment while also improving
Source: www.cochrane.orgCategories: General Medicine NewsTweet-
Source evidence for the recommendation: https://t.co/QsC3kew4Hv Only 1 in 1000 men benefit from psa testing. Many are harmed. https://t.co/dl7zrK5Wkq
-
-
Mashup Score: 3576Elections Canada On-line - Élections Canada en ligne - 3 month(s) ago
Elections Canada is the independent, non-partisan agency responsible for conducting federal elections and referendums.
Source: elections.caCategories: General Medicine NewsTweet-
RT @PierrePoilievre: VOTE for Change TOMORROW. Find your nearest polling location: https://t.co/IY42CBtmjU https://t.co/eC7UeEtctU
-
-
Mashup Score: 496Opinion: It is astonishing – and reprehensible – that Paul Chiang remains a Liberal candidate - 3 month(s) ago
The Markham-Unionville MP called for his political opponent to be handed over to the Chinese consulate in exchange for a bounty
Source: www.theglobeandmail.comCategories: General Medicine NewsTweet-
RT @globeandmail: Opinion: It is astonishing – and reprehensible – that Paul Chiang remains a Liberal candidate https://t.co/jgN6IzT9vT
-
-
Mashup Score: 0
PURPOSEThe standard of care for metastatic castration-resistant prostate cancer (mCRPC) after second-generation androgen receptor pathway inhibitor (ARPI) therapy is still docetaxel. The randomized, double-blind, phase III KEYNOTE-921 trial (…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Seriously: now imagine a study where instead of docetaxel as the control arm, they used ARAT or switch ARAT… And there you have the problem with the PARP studies in prostate cancer. https://t.co/AVDdV4JFZX
-
-
Mashup Score: 1Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world setting☆ - 5 month(s) ago
Randomized controlled trials have shown inconsistent overall survival (OS) benefit among the three cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) as first-line (1L) treatment of patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer (mBC). Several real-world studies compared CDK4/6i effectiveness, with inconsistent findings. This study compared overall survival (OS) of patients with HR+/HER2− mBC receiving 1L palbociclib, ribociclib, or abemaciclib, in combination with an aromatase inhibitor (AI), in US clinical practice.
Source: www.esmoopen.comCategories: General Medicine News, Hem/OncsTweet-
No difference among CDK4/6i in 1L met breast cancer HR+ve HER2 normal Via RWD @myESMO https://t.co/nl763qOMWv
-
-
Mashup Score: 2
Non-Fiction · 2024
Source: books.apple.comCategories: General Medicine News, Hem/OncsTweet-
Listening @janephilpott book and I have thoughts. 1️⃣❤️ listening to her. Always appreciate when author does the audio book. 2️⃣much respect for her work with MSF. 3️⃣comes across as compassionate and passionate. 4️⃣missed opportunity🤔 about 🏥 🧵 https://t.co/aKmUslK74O
-
-
Mashup Score: 0How the World Became Rich - 5 month(s) ago
Business & Personal Finance · 2023
Source: books.apple.comCategories: General Medicine News, Hem/OncsTweet-
“Exports are the price we pay for imports” “A person or nation, fully employed, wants to acquire goods (and services) not get rid of them.” “Exports are a sacrifice we make to acquire imports.” https://t.co/mirm3MBg3h
-
-
Mashup Score: 1The Use of Historical Controls in Clinical Trials, With Dr Althouse - 5 month(s) ago
Podcast Episode · JAMAevidence JAMA Guide to Statistics and Methods · 2025-02-06 · 21m
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet-
@ADAlthousePhD on historical controls. Not one lifting reference…🏋️ https://t.co/y1GNNq8JWP
-
RT @SheilaGunnReid: READ THE FULL REPORT HERE: https://t.co/Qd7VUPOzEh